ClinVar Miner

Submissions for variant NM_014159.7(SETD2):c.638C>G (p.Ala213Gly)

gnomAD frequency: 0.00001  dbSNP: rs1292986984
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
New York Genome Center RCV003448568 SCV004176057 uncertain significance Luscan-Lumish syndrome 2023-06-22 criteria provided, single submitter clinical testing The c.638C>G variant in SETD2 has not previously been reported in the literature and the variant is observed in 2 alleles (~0.0003% minor allele frequency with 0 homozygotes) in population databases (gnomAD v2.1.1 and v3.1.2, TOPMed Freeze 8), suggesting it is not a common benign variant in the populations represented in those databases. The c.638C>G variant in SETD2 is located in exon 3 of this 21-exon gene and predicted to replace a moderately conserved alanine amino acid with glycine at position 213 in the kinase domain of the encoded protein. In silico predictions are not in favor of damaging effect for p.(Ala213Gly) [(CADD v1.6 = 21.3, REVEL = 0.116)]; however, there are no functional studies to support or refute these predictions. Based on available evidence this inherited c.638C>G p.(Ala213Gly) variant in SETD2 is classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.